Psilocybin Therapy for Depression in Parkinson's Disease
NCT06455293
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Depression
Interventions
DRUG:
Psilocybin
Sponsor
Joshua Woolley, MD, PhD